These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32443660)

  • 1. Gallic Acid Inhibits Lipid Accumulation via AMPK Pathway and Suppresses Apoptosis and Macrophage-Mediated Inflammation in Hepatocytes.
    Tanaka M; Sato A; Kishimoto Y; Mabashi-Asazuma H; Kondo K; Iida K
    Nutrients; 2020 May; 12(5):. PubMed ID: 32443660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.
    Zhang J; Zhang W; Yang L; Zhao W; Liu Z; Wang E; Wang J
    Phytomedicine; 2023 Jan; 109():154589. PubMed ID: 36610145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
    Wang H; Huang M; Bei W; Yang Y; Song L; Zhang D; Zhan W; Zhang Y; Chen X; Wang W; Wang L; Guo J
    Biomed Pharmacother; 2021 Jun; 138():111532. PubMed ID: 34311531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.
    Li J; Xie S; Teng W
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
    Ganji SH; Kashyap ML; Kamanna VS
    Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway.
    Gai H; Zhou F; Zhang Y; Ai J; Zhan J; You Y; Huang W
    J Food Sci; 2020 Nov; 85(11):4050-4060. PubMed ID: 33037652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lemon Balm and Its Constituent, Rosmarinic Acid, Alleviate Liver Damage in an Animal Model of Nonalcoholic Steatohepatitis.
    Kim M; Yoo G; Randy A; Son YJ; Hong CR; Kim SM; Nho CW
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32331258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
    Patel TP; Rawal K; Soni S; Gupta S
    Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
    Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo.
    Liang C; Li Y; Bai M; Huang Y; Yang H; Liu L; Wang S; Yu C; Song Z; Bao Y; Yi J; Sun L; Li Y
    Pharmacol Res; 2020 Mar; 153():104657. PubMed ID: 31982488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
    Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
    World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of
    Mun J; Park J; Yoon HG; You Y; Choi KC; Lee YH; Kim K; Lee J; Kim OK; Jun W
    J Med Food; 2019 Dec; 22(12):1262-1270. PubMed ID: 31834842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways.
    Chen KY; Lin JA; Yao HY; Hsu AC; Tai YT; Chen JT; Hsieh MC; Shen TL; Hsu RY; Wu HT; Wang GH; Ho BY; Chen YP
    Nutr Res; 2018 Apr; 52():87-97. PubMed ID: 29525610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
    Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
    BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
    Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
    Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
    Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
    Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
    Kim M; Yoo G; Randy A; Kim HS; Nho CW
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Octyl Itaconate Prevents Free Fatty Acid-Induced Lipid Metabolism Disorder through Activating Nrf2-AMPK Signaling Pathway in Hepatocytes.
    Chu X; Li L; Yan W; Ma H
    Oxid Med Cell Longev; 2022; 2022():5180242. PubMed ID: 35222799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.